{
    "medicine_id": "9ccf1b14f9bb699dd66e48c4de4c0aba6cba89e5",
    "platform_id": "DB05228",
    "metadata": {
        "name": "Eucrisa 20 mg 1g Ointment",
        "composition": "20 mg 1g RDEA806",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of HIV 1 infection in combination with appropriate antiretroviral agents when therapy is warranted",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "RDEA806 is a potent HIV non nucleoside reverse transcriptase inhibitor NNRTI with a high genetic barrier to resistance and a broad spectrum of activity RDEA806 is highly active in vitro against wild type and the majority of HIV strains carrying key reverse transcriptase mutations RDEA806 has the potential to be used in both naive and treatment experienced patients and has a much higher barrier to resistance than currently approved NNRTIs which could translate into delayed onset of resistance",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}